|
⚲
|
| Summit Life Sciences LP | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001475827 |
| Sale | 2009-10-26 ($100.0 M Offered, $25.0 M Sold) |
| Fund | |
| Phone | 9258762765 |
| Address | 13512 Aintree Avenue Draper, 84020 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Jeffrey Smith | |
| Summit Life Sciences Partners LLC | |
| Shawn Fojtik | |
| Robert Mitchell |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Berkshire Multifamily Value Plus Fund III, L.P.
✚
|
0.0 | |
|
Berry Brett M
✚
|
0.0 | |
|
Berry Robert C Jr.
✚
|
0.0 | |
|
FL5 Fund I, a series of Roll Up Vehicles, LP
✚
|
0.0 | |
|
FLE Fund I, a series of DVC, LP
✚
|
0.0 | |
|
FLE Fund I, a series of Zachary Ginsburg Funds, LP
✚
|
0.0 | |
|
Fleming James A
✚
|
0.0 | |
|
Flinois Xavier
✚
|
0.0 | |
|
FLYR, Inc.
✚
|
0.0 | |
|
Berkshire FF Multifamily Co-Investment Fund, L.P.
✚
|
0.0 |